Cardiovascular events, diabetes and guidelines: the virtue of simplicity
- PMID: 30922303
- PMCID: PMC6437845
- DOI: 10.1186/s12933-019-0844-y
Cardiovascular events, diabetes and guidelines: the virtue of simplicity
Abstract
Cardiovascular (CV) events or their minor syndromes, as various forms of ischemia, are medical emergencies that do not allow enough time for a guiding anamnesis or proper clinical examination, and lead to relying on Treatment Guidelines, but in many situations it is appropriate to deviate from them. Pathological studies have associated 75% of coronary artery events with atherosclerotic plaque rupture; it is now known that rupture alone is not enough for obstruction or occlusion of the vessel lumen. Concomitant conditions are required for the clinical manifestation of cardiovascular disease, including prothrombogenic and dysfunctional endothelium, less fibrinolytic capacity to protect it, increased platelet activation, increased adrenergic tone, microcirculation vasoconstriction, and other countless factors that contribute to thrombus formation, causing ischemia or infarction. But in most cases, repair of plaque rupture and re endothelization of the lesion are asymptomatic and silent. Atherosclerotic process is a chronic and progressive immune inflammation. Most of the therapeutic indications include statins, which cause side effects in 10% of patients, with a range varying between 7 and 21%, according to different authors. Many investigators have proved that statin use contribute to the genesis of diabetes, reports vary between 1 and 46%, where marked elevation of blood glucose fasting levels and glycosylated hemoglobin have been observed, be it by increased tissue resistance to insulin or by reduced β-cell insulin secretion. Physicians should base their indications on the recommendations provided by Guidelines, but they should not forget that every patient is different, and they should not get confused due to lack of time in an emergency nor be influenced by the latest publications or techniques until they have been properly tested.
Keywords: Atherosclerosis; Cardiovascular events; Diabetes; Endothelial dysfunction; Statins.
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, Jr, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis American Heart Association. Circulation. 1994;89:2462–2478. doi: 10.1161/01.CIR.89.5.2462. - DOI - PubMed
-
- Libby P, Folco EJ, Esper RJ. Inmunidad, inflamación y ateroesclerosis. In: Esper RJ, Vilariño JO (Eds): Progresos en Ateroesclerosis, Buenos Aires, Ediciones Médicas del Sur, 2011, p. 23–47.
-
- Viles-Gonzalez JF, Fuster V, Esper RJ, Vilariño JO, Badimon JJ: Enfermedad Aterotrombótica. In: Esper RJ (Ed): Aterotrombosis en el tercer milenio. Barcelona, Prous Sciences, 2004, p. 1–22.
-
- Esper RJ. Ateroesclerosis, una enfermedad inmuno-inflamatoria. Prensa Med Argent. 2009;96:552–570.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
